West Pharmaceutical Services logo

West Pharmaceutical Services Balance Sheet Statement

Assets, liabilities, and shareholders' equity

West Pharmaceutical Services holds $4.1B in total assets. Shareholders' equity is $3.0B against $321.0M in total debt. Cash and equivalents total $521.4M. The current ratio is 2.71 and debt-to-equity is 0.107. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-04-23
Market Cap$21.5B
P/E Ratio39.63
ROE19.13%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$239.3M$228.4M$239.0M$255.8M$253.7M$252.3M
Accrued expenses$39.2M$46.6M
Other Commercial Liabilities$39.2M$46.6M
Contract liabilities$53.2M$47.8M$46.2M$47.3M$53.7M$62.2M
Accrued Income Taxes, Current$31.5M$22.3M$28.5M$33.3M$28.1M$78.9M
Accrued Liabilities, Current$39.2M$46.6M
Accrued salaries, wages and benefits$73.5M$67.8M$93.4M$111.8M$135.9M$72.6M
Other accrued liabilities$188.2M$186.4M$222.8M$213.1M$175.3M$202.2M
Current portion of long-term debt$0.0$0.0$0.0$0.0$0.0$0.0
Deferred revenue$3.1M$2.8M$4.3M$3.8M
Finance Lease Liability, Current$900.0K$1.5M
Finance Lease Liability Payment Due$4.4M$5.4M$5.9M$5.2M
Finance Lease Liability - Undiscounted Excess Amount$200.0K$500.0K$500.0K$400.0K
Income taxes payable$31.5M$22.3M$28.5M$33.3M$28.1M$78.9M
Lease Liability Payments - 2020 (Remaining Three Months)$18.7M$13.3M$6.5M$21.0M
Lease Liability Payments - 2021$1.2M$1.3M$1.5M$1.5M
Operating Lease Liability Payments - 2024 (Lessee)$17.5M$18.2M$18.4M$20.2M
Operating Lease Liability Payments - 2025 (Lessee)$12.3M$12.8M$12.7M$10.4M
Lease Liability Payments - Due Year Two$1.1M$1.3M$1.5M$1.1M
Lease Liability Payments - Due Year Three$16.0M$16.7M$16.6M$15.0M
Lease Liability Payments - Due Year Four$12.3M$12.8M$12.7M$10.4M
Lease Liability Payments - Remainder of Fiscal Year$900.0K$700.0K$400.0K$1.1M
Note payable to DIRECTV$188.2M$186.4M$222.8M$213.1M$175.3M$202.2M
Operating lease liabilities, current$17.9M$21.8M$20.9M$21.4M$22.7M$21.4M
Operating Lease Liability Payments Due$113.7M$113.5M$106.9M$140.3M
Operating Lease Liability - Undiscounted Excess Amount$13.1M$12.8M$12.0M$26.9M
Total current liabilities$550.4M$526.7M$604.6M$635.4M$654.9M$674.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Cumulative Cost Basis$3.0B$3.0B$3.2B$3.2B$3.2B$3.2B
Business Combination, Contingent Consideration, Liability$3.0M$2.4M$2.3M$2.8M$2.2M$3.0M
Common stock, par value (in dollars per share)$0.3$0.3$0.3$0.3$0.3$0.3
Common stock, shares authorized (in shares)$200.0M$200.0M$200.0M$200.0M$200.0M$200.0M
Common stock, shares issued (in shares)$75.3M$75.3M$75.3M$75.3M$75.3M$75.3M
Common Stock, Shares, Outstanding$72.3M$71.8M$71.9M$71.9M$72.0M$70.9M
Contract with Customer, Asset, after Allowance for Credit Loss$23.3M$25.8M$27.9M$27.5M$11.9M$15.4M
Contract with Customer, Liability$53.2M$47.8M$46.2M$47.3M$53.7M$62.2M
Long-term debt, gross$203.0M$203.0M$203.0M$203.0M$203.0M$203.0M
Debt Instrument, Fair Value Disclosure$200.5M$201.2M$201.9M$202.1M$202.4M$202.2M
Deferred Compensation Liability, Classified, Noncurrent$15.4M$11.4M$12.5M$13.5M$13.5M$11.8M
Deferred compensation plan assets$11.1M$8.5M$9.5M$10.0M$10.0M$8.7M
Deferred income taxes$20.5M$21.3M$23.0M$22.8M$23.0M$22.7M
Current maturities of long-term debt$900.0K$1.1M$1.3M$1.5M$1.5M$1.5M
Finance Lease Liability Payments Due$4.4M$5.4M$5.9M$5.2M
2027$1.2M$1.3M$1.5M$1.5M
Finance Lease Liability Payments Due Year Four$300.0K$400.0K$500.0K$400.0K
Finance Lease Liability Payments Due Year Three$700.0K$900.0K$1.1M$600.0K
Finance Lease Liability Payments Due Year Two$1.1M$1.3M$1.5M$1.1M
Thereafter$200.0K$800.0K$900.0K$500.0K
Finance Lease Liability Undiscounted Excess Amount$200.0K$500.0K$500.0K$400.0K
Finance Lease, Right-of-Use Asset, after Accumulated Amortization$29.7M$32.0M$35.0M$35.2M$34.7M$34.0M
Lessee Operating Lease Liability Payments Due$113.7M$113.5M$106.9M$140.3M
Thereafter$26.9M$27.4M$27.3M$52.6M
Lessee Operating Lease Liability Undiscounted Excess Amount$13.1M$12.8M$12.0M$26.9M
Operating Lease Weighted Average Discount Rate Percent$0.0$0.0$0.0$0.0$0.0$0.0
Deferred compensation liabilities$11.2M$8.6M$9.6M$10.1M$10.1M$8.8M
Preferred Stock, Shares Authorized$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M
Preferred Stock, Shares Issued$0.0$0.0$0.0$0.0$0.0$0.0
Preferred Stock, Shares Outstanding$0.0$0.0$0.0$0.0$0.0$0.0
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied$3.1M$2.8M$4.3M$3.8M
Incentive stock program, shares reserved for future grants (in shares)$1.1M$3.1M$3.0M$2.8M
Treasury stock, shares (in shares)$3.0M$3.5M$3.4M$3.4M$3.3M$4.4M
Unamortized Debt Issuance Expense$400.0K$400.0K$400.0K$300.0K$200.0K$200.0K
Unrecognized tax benefits$56.1M$64.7M
Remainder of Fiscal Year 2024$18.7M$13.3M$6.5M$21.0M
Weighted-Average Discount Rate4.8%4.5%4.3%4.2%4.2%4.1%
Weighted-Average Discount Rate - Finance Leases$0.0$0.0$0.0$0.0$0.0$0.0